Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sinusitis
Pharma
Optinose delivery system hits primary goals in sinusitis phase 3
Using the system to deliver fluticasone propionate sparked improvements in symptoms and an objective measure of disease in the sinus cavities.
Nick Paul Taylor
Mar 8, 2022 8:00am
Lyra data on steroid-eluting implant open up 505(b)(2) pathway
Jul 6, 2021 7:05am
Amgen-Kyowa Kirin, J&J-Legend, CStone—Fierce Pharma Asia
Jun 4, 2021 5:44am
SinuSys accesses nano-emulsion platform to boost sinus delivery
Jan 25, 2021 7:55am
Dupixent scores FDA approval in sinusitis with nasal polyps
Jun 26, 2019 2:08pm
Novartis' Xolair eyes sinusitis to backstop blockbuster sales
Jun 4, 2019 12:51pm
